These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31324203)

  • 21. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
    Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAR2 Inhibition Enhanced the Sensitivity of Colorectal Cancer Cells to 5-FU and Reduced EMT Signaling.
    Quan Q; Zhong F; Wang X; Chen K; Guo L
    Oncol Res; 2019 Jul; 27(7):779-788. PubMed ID: 30841957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer
    Deng L; Zhao Y; Liu W
    J Chemother; 2024 Sep; 36(5):422-434. PubMed ID: 38044588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer.
    Xu Y; Zhu M
    Clin Transl Oncol; 2020 Jul; 22(7):1105-1116. PubMed ID: 31728833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of STAT3/cyclinD1 pathway promotes chemotherapeutic sensitivity of colorectal caner.
    Qin A; Yu Q; Gao Y; Tan J; Huang H; Qiao Z; Qian W
    Biochem Biophys Res Commun; 2015 Feb; 457(4):681-7. PubMed ID: 25617735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
    Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic reversal of acquired resistance to 5-fluorouracil treatment.
    Humeniuk R; Mishra PJ; Bertino JR; Banerjee D
    Mol Cancer Ther; 2009 May; 8(5):1045-54. PubMed ID: 19383845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
    Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY; Lee JS; Min HY; Lee HY
    Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer.
    Qin J; Hu S; Lou J; Xu M; Gao R; Xiao Q; Chen Y; Ding M; Pan Y; Wang S
    Int Immunopharmacol; 2024 Aug; 137():112487. PubMed ID: 38889513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Li J; Li X; Cen C; Ai X; Lin C; Hu G
    Oncol Rep; 2018 Jan; 39(1):217-226. PubMed ID: 29115526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 regulates 5-Fu resistance in human colorectal cancer cells by promoting Mcl-1-dependent cytoprotective autophagy.
    Yue Y; Zhang Q; Wang X; Sun Z
    Cancer Sci; 2023 Jun; 114(6):2293-2305. PubMed ID: 36788743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation.
    Sahebnasagh R; Deli H; Shadboorestan A; Vakili-Ghartavol Z; Salehi N; Komeili-Movahhed T; Azizi Z; Ghahremani MH
    PLoS One; 2024; 19(10):e0311680. PubMed ID: 39401197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
    Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
    J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.
    Yang Y; Ma L; Xu Y; Liu Y; Li W; Cai J; Zhang Y
    Cell Death Dis; 2020 Jun; 11(6):477. PubMed ID: 32581212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells.
    Ding W; Wang JX; Wu JZ; Liu AC; Jiang LL; Zhang HC; Meng Y; Liu BY; Peng GJ; Lou EZ; Mao Q; Zhou H; Tang DL; Chen X; Liu JB; Shi XP
    Acta Pharmacol Sin; 2023 Dec; 44(12):2537-2548. PubMed ID: 37528233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.
    Wang W; Guo W; Li L; Fu Z; Liu W; Gao J; Shu Y; Xu Q; Sun Y; Gu Y
    Biochem Pharmacol; 2016 Dec; 121():8-17. PubMed ID: 27693317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms.
    Marjaneh RM; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
    J Cell Physiol; 2019 Mar; 234(3):2306-2316. PubMed ID: 30191973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.